Active Technology has recently completed an Angel+ financing round of RMB 464 million. The round was jointly led by Gaorong Ventures, SDIC Capital, and Shanghai Science and Technology Innovation Investment, with participation from Kangjun Capital, China Internet Investment Fund, Guotai Haitong, Pudong Venture Capital, Shanghai Science and Technology Innovation Fund, Guangzhou Pharmaceutical Capital, Minjin Investment, and Yunqi Capital. Existing shareholders Daotong Capital, BGI Songhe, and Inno Capital also made additional investments. The proceeds will be used to advance R&D in invasive brain-computer interfaces, facilitate clinical translation and industrialization, and expand industry collaboration.